Announcement on Voluntary Closure of the Commercialization Cooperation for Vecantoxatug Monoclonal Antibody Injection and Silevimig Monoclonal Antibody Injection

About this update from Chongqing Genrix Biopharmaceutical Co., Ltd. Class A

Announcement on Voluntary Closure of the Commercialization Cooperation for Vecantoxatug Monoclonal Antibody Injection and Silevimig Monoclonal Antibody InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chongqing Genrix Biopharmaceutical Co., Ltd. Class A